铂金
化疗
医学
癌症
肺癌
肿瘤科
内科学
生物
生物化学
催化作用
作者
Giannis Mountzios,Longhua Sun,Byoung Chul Cho,Umut Demırcı,Sofia Baka,Mahmut Gümüş,Antonio Lugini,Bo Zhu,Yan Yu,Ippokratis Korantzis,Ji‐Youn Han,Tudor‐Eliade Ciuleanu,Myung‐Ju Ahn,Pedro Rocha,Julien Mazières,Sally C. M. Lau,Martin Schüler,Fiona Blackhall,Tatsuya Yoshida,Taofeek K. Owonikoko
标识
DOI:10.1056/nejmoa2502099
摘要
Treatment with tarlatamab led to longer overall survival than chemotherapy among patients with small-cell lung cancer whose disease had progressed during or after platinum-based chemotherapy. (Funded by Amgen; DeLLphi-304 ClinicalTrials.gov number, NCT05740566.).
科研通智能强力驱动
Strongly Powered by AbleSci AI